Literature DB >> 16239180

Behavioural changes and psychological symptoms in dementia disorders.

Ian McKeith1, Jeffrey Cummings.   

Abstract

The traditional view of dementia is that the features most important to accurate diagnosis and management are cognitive decline and functional disability. Behavioural and psychological symptoms have generally been thought to be of secondary importance, but new evidence suggests that these are important determinants of patients' distress, carer burden, and outcome in dementia; they can also be valuable diagnostic pointers to the underlying pathological cause and disease diagnosis. Better methods to detect and measure the severity of behavioural and psychological symptoms are needed and these could be used in well-designed intervention trials. Although pharmacological management is a commonly used option, it is often limited in its effects and can be associated with a substantial risk of side-effects. Progress in understanding the pathophysiological mechanisms underpinning behavioural and psychological symptoms in dementia will assist in developing more effective treatment approaches.

Entities:  

Mesh:

Year:  2005        PMID: 16239180     DOI: 10.1016/S1474-4422(05)70219-2

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  42 in total

Review 1.  The role of phytochemicals in the treatment and prevention of dementia.

Authors:  Melanie-Jayne R Howes; Elaine Perry
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

Review 2.  Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.

Authors:  Fernando Calahorro; Manuel Ruiz-Rubio
Journal:  Invert Neurosci       Date:  2011-11-08

Review 3.  PET/CT in diagnosis of dementia.

Authors:  Valentina Berti; Alberto Pupi; Lisa Mosconi
Journal:  Ann N Y Acad Sci       Date:  2011-06       Impact factor: 5.691

4.  Role of citalopram in the treatment of agitation in Alzheimer's disease.

Authors:  Anton P Porsteinsson; Melanie A Keltz; Jessica S Smith
Journal:  Neurodegener Dis Manag       Date:  2014

5.  Pharmacological management of neuropsychiatric symptoms in patients with major neurocognitive disorders.

Authors:  Dominique Elie; Soham Rej
Journal:  J Psychiatry Neurosci       Date:  2018-01       Impact factor: 6.186

6.  Relationship satisfaction and emotional language in frontotemporal dementia and Alzheimer disease patients and spousal caregivers.

Authors:  Elizabeth A Ascher; Virginia E Sturm; Benjamin H Seider; Sarah R Holley; Bruce L Miller; Robert W Levenson
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jan-Mar       Impact factor: 2.703

7.  Intravoxel incoherent motion diffusion-weighted imaging in the characterization of Alzheimer's disease.

Authors:  Nengzhi Xia; Yanxuan Li; Yingnan Xue; Weikang Li; Zhenhua Zhang; Caiyun Wen; Jiance Li; Qiong Ye
Journal:  Brain Imaging Behav       Date:  2021-09-04       Impact factor: 3.978

Review 8.  Approach to inappropriate sexual behaviour in people with dementia.

Authors:  Petra Joller; Neeraj Gupta; Dallas P Seitz; Christopher Frank; Michelle Gibson; Sudeep S Gill
Journal:  Can Fam Physician       Date:  2013-03       Impact factor: 3.275

9.  Neuropsychiatric features of frontal lobe dysfunction in autopsy-confirmed patients with lewy bodies and "pure" Alzheimer disease.

Authors:  Guerry M Peavy; David P Salmon; Steven D Edland; Steven Tam; Lawrence A Hansen; Eliezer Masliah; Douglas Galasko; Joanne M Hamilton
Journal:  Am J Geriatr Psychiatry       Date:  2013-03-13       Impact factor: 4.105

Review 10.  How fisetin reduces the impact of age and disease on CNS function.

Authors:  Pamela Maher
Journal:  Front Biosci (Schol Ed)       Date:  2015-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.